Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Clinical Trials Market

Clinical Trials Market Share

Report ID: GMI5029
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Clinical Trials Market Share

The global clinical trials industry is marked by a diverse range of stakeholders, including pharmaceutical and biotechnology companies, CROs, academic institutions, and healthcare providers. Key players in the market have established themselves through comprehensive service offerings that include clinical trial management, clinical trial data management systems, regulatory affairs, and patient recruitment. In addition, the companies are leveraging cutting-edge technologies such as artificial intelligence (AI) and machine learning to streamline trial efficiency and enhance data analysis capabilities to further solidify their market presence.

Clinical Trials Market Companies

Few of the prominent players operating in the clinical trials industry include:

Charles River Laboratories (MPI Research)
Clinipace Inc.
Eli Lilly and Company
ICON plc
IQVIA Inc
Laboratory Corporation of America Holdings (Covance Inc)
Medpace, Inc.
Merck & Co
Parexel International Corporation
Pfizer Inc.
SGS SA
Syneos Health
The Emmes Company, LLC
Thermo Fisher Scientific (PPD Inc)
Veeda Clinical Research
Worldwide Clinical Trials
WuXi AppTech

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Clinical trials industry size was USD 55.8 billion in 2023 and is estimated to witness 5.4% CAGR from 2024 to 2032 due to the increasing prevalence of chronic diseases and the subsequent demand for innovative therapies.

The phase II segment of the clinical trials industry recorded a revenue of USD 23.4 billion in 2023 and is anticipated to strike 5.2% CAGR through 2032 owing to the growing number of industry-sponsored and non-industry-sponsored clinical trials in phase II.

Clinical trials market from the outsourcing service segment is projected to reach USD 58.3 billion by 2032 due to the increasing complexity of clinical trials and the need for specialized expertise.

U.S. clinical trials industry size was USD 27.3 billion in 2023 and is anticipated to grow by 2032, driven by a well-established healthcare system and infrastructure, with significant government and private investments in R&D.